Anzeige
Mehr »
Samstag, 21.03.2026 - Börsentäglich über 12.000 News
Das "Next Butte?"-Setup in Montana - und es ist noch immer eine $15M-Story
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41MRZ | ISIN: US81727U3032 | Ticker-Symbol: 6L60
Tradegate
19.03.26 | 13:12
5,450 Euro
-2,68 % -0,150
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SENSEONICS HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
SENSEONICS HOLDINGS INC 5-Tage-Chart
RealtimeGeldBriefZeit
5,4505,50010:34
5,5005,70020.03.

Aktuelle News zur SENSEONICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoSenseonics reports sustained year-long CGM implant outcomes, insulin pump integration benefits13
14.03.Senseonics Holdings, Inc.: First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear2
12.03.Senseonics Holdings, Inc. - 8-K, Current Report1
03.03.Stifel reiterates Hold on Senseonics stock, cites cash burn concerns5
03.03.Senseonics Q4 Revenue Jumps 72%, Expects FY26 Revenue To Grow 65-76%4
03.03.Senseonics targets $58M-$62M 2026 revenue as company integrates sales operations and accelerates direct-to-consumer strategy7
02.03.Protokoll des Earnings Call: Senseonics Q4 2025 mit gemischten Ergebnissen1
SENSEONICS Aktie jetzt für 0€ handeln
02.03.Senseonics earns FDA IDE for next-gen Gemini CGM, posts Q4 revenue beat-
02.03.Senseonics Holdings, Inc. - 10-K, Annual Report2
02.03.Senseonics Holdings, Inc. - 8-K, Current Report1
02.03.Senseonics Holdings: Q4 Earnings Insights2
02.03.Senseonics reports Q4 results1
02.03.Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results207Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year Received CE Mark approval for commercialization of Eversense 365 in Europe Launched first Eversense 365 AID system integration...
► Artikel lesen
27.02.Senseonics Q4 2025 Earnings Preview1
27.02.Preview: Senseonics Holdings' Earnings1
19.02.Sequel, Senseonics announce full launch of Eversense 365 CGM, twiist pump pairing1
19.02.Senseonics Holdings, Inc.: Sequel Med Tech and Senseonics Launch Transformative Combination of twiist and Eversense 3653
29.01.Senseonics wins CE mark for Eversense 365 year-long CGM1
29.01.Senseonics receives CE mark for one-year CGM system in Europe1
29.01.Senseonics Holdings, Inc.: Senseonics Receives European Approval for Eversense 365, World's Longest-lasting Continuous Glucose Monitor657GERMANTOWN, Md., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous...
► Artikel lesen
Weiter >>
53 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1